Image 7_In-depth analysis for TKI-driven real-world management of 201 CML patients using TFR.jpeg

Background<p>Tyrosine-kinase inhibitors (TKIs) have reshaped chronic myeloid leukemia (CML) outcomes, but real-world data from Eastern Europe remain scarce.</p>Methods<p>We retrospectively analyzed 201 adult patients with CML managed at the Cluj-Napoca Department of Haematology (Ja...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Mihnea Lucian Micu (22571075) (author)
مؤلفون آخرون:	Simion Florin Cira (22571078) (author), Mihnea Zdrenghea (6032852) (author), Anca Bojan (3761365) (author), Andrada Parvu (22571081) (author), Tunde Torok-Vistai (22571084) (author), Anca Vasilache (22571087) (author), Laura Urian (22571090) (author), Bancos Anamaria (22571093) (author), Laura Ioana Jimbu (22571096) (author), Maria-Elena Santa (22571099) (author), Diana Lighezan (22571102) (author), Adrian Bogdan Tigu (8678637) (author), Andrei Ivancuta (22571105) (author), Adrian Trifa (6032819) (author), Elena-Cristina Selicean (22571108) (author), Delia Dima (6032807) (author), Rus Ioana Codruța (22571111) (author), Ciprian Tomuleasa (3761362) (author)
منشور في:	2025
الموضوعات:	Pharmacology bioinformatics & computational biology machine learning chronic myeloid leukemia treatment free remission (TFR) real world evidence (RWE)
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Image 7_In-depth analysis for TKI-driven real-world management of 201 CML patients using TFR.jpeg

مواد مشابهة